Exane Derivatives’s Sempra SRE Stock Holding History

Exane Derivatives’s Portfolio SRE Stock Details SRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$215K	Sell	2,862 -7,322	-72%	-$588K	0.12%	153
2022 Q1	$856K	Sell	10,184 -2,442	-19%	-$175K	0.24%	112
2021 Q4	$835K	Buy	12,626 +7,430	+143%	+$471K	0.2%	107
2021 Q3	$329K	Buy	5,196 +810	+18%	+$53.5K	0.08%	262
2021 Q2	$290K	Buy	4,386 +3,568	+436%	+$244K	0.07%	296
2021 Q1	$54.2K	Buy	818 +124	+18%	+$7.71K	0.02%	506
2020 Q4	$44.2K	Buy	694 +292	+73%	+$18.8K	0.01%	466
2020 Q3	$23.8K	Buy	+402	New	+$24.7K	0.01%	423
2017 Q2	–	Sell	-1,438	Closed	-$79.4K	–	678
2017 Q1	$79.4K	Sell	1,438 -512	-26%	-$27.2K	0.02%	238
2016 Q4	$98.1K	Buy	1,950 +630	+48%	+$32.1K	0.02%	254
2016 Q3	$70.7K	Buy	1,320 +524	+66%	+$28.5K	0.01%	271
2016 Q2	$45.4K	Buy	796 +94	+13%	+$4.98K	0.01%	282
2016 Q1	$36.5K	Hold	702	–	–	﹤0.01%	343
2015 Q4	$33K	Sell	702 -446	-39%	-$22K	﹤0.01%	274
2015 Q3	$55.5K	Sell	1,148 -698	-38%	-$34.3K	0.01%	256
2015 Q2	$91.3K	Hold	1,846	–	–	0.01%	253
2015 Q1	$101K	Sell	1,846 -450	-20%	-$24.8K	0.01%	264
2014 Q4	$128K	Buy	+2,296	New	+$125K	0.02%	259

Other funds holding SRE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Exane Derivatives's SRE Position: Q2 2022 in Review

Exane Derivatives reduced its Sempra (SRE) stake by 72% in Q2 2022, selling an estimated $588K and leaving 2,862 shares worth $215K. The position accounts for 0.12% of the portfolio, ranked #153.

Exane Derivatives first reported a position in SRE in Q4 2014 and has held it in 18 quarters since. The position peaked at $856K in Q1 2022. 956 funds tracked by Wall St. Rank hold SRE as of Q2 2022.

Exane Derivatives held 2,862 shares of Sempra worth $215K as of Q2 2022.
Exane Derivatives sold 7,322 Sempra shares in Q2 2022, an estimated $588K.
Sempra made up 0.12% of Exane Derivatives's portfolio in Q2 2022, its #153 holding.
Exane Derivatives first reported a position in Sempra in Q4 2014 and has held it in 18 quarters since.
Exane Derivatives's Sempra position peaked at $856K in Q1 2022.
956 funds tracked by Wall St. Rank held Sempra as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.